Reverse transcriptase PCR and quantitative PCR analysis of the resulting CD24+ tumours confirmed Ptch1 deletion and identified no significant difference in Gli1 and Nmyc expression levels compared with Ptch1lox/lox;GFAPcre medulloblastoma (Fig 2D, 2E and 2F). The gene discussed is MYCN; the disease is neoplasm.